CAV1 and prostate carcinoma: To investigate whether reduced Cav1 expressions might alter the radiation response of malignant prostate epithelial cells we performed in vitro experiments using the human prostate carcinoma cell line PC3 in combination with shRNA knock-down of Cav1 expression (Fig. 1).